Clinical Trials
22 trialsPatent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
Faculty of Medicine of Tunis
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
M.D. Anderson Cancer Center
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
M.D. Anderson Cancer Center
RACC
Karolinska Institutet
VULCA-NODE
Hospital Universitario La Paz
Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
Istanbul University
SLN
Istanbul University
LYSE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SENTIX
Charles University, Czech Republic
SNEX
Karolinska University Hospital
Lymph Node Mapping in Patients With Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Early Feasibility Study of the "Easy Light" Fluorecence Imaging System
Professor Fernando Figueira Integral Medicine Institute
Complications of Laparoscopic Hysterectomy and Sentinel Lymph Node Biopsy for Endometrial Carcinoma
Ain Shams Maternity Hospital
SYSUGO-005
Sun Yat-sen University
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Case Comprehensive Cancer Center
SNE
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
SLNMIEC
Peking University People's Hospital
SLNMICC
Peking University People's Hospital
Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer
Centre hospitalier de l'Université de Montréal (CHUM)
GroSNaPET
Catholic University of the Sacred Heart
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.
Women and Infants Hospital of Rhode Island
Sentinel Node Biopsy in Endometrial Cancer
Hamilton Health Sciences Corporation